Gene · 59341
Papers4,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Monopolar Radiofrequency for Facial Hyperpigmentation Treatment: An Integrated Retrospective Clinical Trial and Ex Vivo Study. | Int J Mol Sci | 2026 | 41596410 | PubTator, text mining | PubMed |
| A mechanically active nucleus pulposus-on-a-chip for studying mechanobiology and therapeutic strategies in intervertebral disc disease. | Biofabrication | 2026 | 41587538 | PubTator, text mining | PubMed |
| MA-T Activates Human TRPV4 in the Non-pigmented Ciliary Epithelial Cells. | Biol Pharm Bull | 2026 | 41581922 | PubTator, text mining | PubMed |
| Activation of TRPV4 to drive pyroptosis-dependent orthodontic tooth remodeling. | Sci Prog | 2026 | 41569001 | PubTator, text mining | PubMed |
| An update on regulation of the polymodal TRPV4 channel by protein phosphorylation. | Channels (Austin) | 2026 | 41555550 | PubTator, text mining | PubMed |
| Corrigendum to "The role of TRPV4 in acute sleep deprivation-induced memory impairment: Mechanisms of calcium dysregulation and synaptic plasticity disruption." [Cell Insight 4 (2025) 100240]. | Cell Insight | 2026 | 41541798 | PubTator, text mining | PubMed |
| Characterization of the Functional Transient Receptor Potential Vanilloid Channels 1 to 4 in Human Corneal Endothelial Cells. | Invest Ophthalmol Vis Sci | 2026 | 41533920 | PubTator, text mining | PubMed |
| Pathogenesis and Therapeutics for Chronic Pruritus of Unknown Origin: A Systematic Review. | Int J Dermatol | 2026 | 41531005 | PubTator, text mining | PubMed |
| The emerging role of TRPV4 in skeletal biology: Mechanotransduction, mutation, and therapeutic potential. | Cell Calcium | 2026 | 41529958 | PubTator, text mining | PubMed |
| Mechanoresponsive ion channels Piezo1 and TRPV4 stimulate ADAM10 and ADAM17 with differential impact on endothelial migration and proliferation. | Cell Commun Signal | 2026 | 41519760 | PubTator, text mining | PubMed |
| TRPV4 regulates intraocular pressure through trabecular meshwork contractility and fibrosis. | Channels (Austin) | 2026 | 41518035 | PubTator, text mining | PubMed |
| Transient receptor potential vanilloid four in macrophages mediates TGF-β activation to drive myofibroblast differentiation and pulmonary fibrosis. | J Biol Chem | 2026 | 41513093 | PubTator, text mining | PubMed |
| Remodeling of skull bone channels regulates immune infiltration into the meninges during neuroinflammation. | Immunity | 2026 | 41468886 | PubTator, text mining | PubMed |
| Feeling the pressure: TRPV4's mechanosensitive side. | J Hypertens | 2026 | 41459794 | PubTator, text mining | PubMed |
| Importance of Endothelial TRPV4 Ion Channel in Myocardial Ischemia-reperfusion. | Can J Cardiol | 2026 | 41456704 | PubTator, text mining | PubMed |
| Osteoarthritis year in review 2025: Biology. | Osteoarthritis Cartilage | 2026 | 41418993 | PubTator, text mining | PubMed |
| Enteric gliosis induced by TRPV4 alleviates intestinal excessive-motility through Ca2+ signaling. | Neuropharmacology | 2026 | 41412513 | PubTator, text mining | PubMed |
| Post-hemorrhagic hydrocephalus: a neuroinflammatory perspective on CSF hypersecretion and ventricular enlargement. | Int Immunopharmacol | 2026 | 41406835 | PubTator, text mining | PubMed |
| TRPV4-mediated mechanotransduction of matrix stiffness in the pathogenesis, progression, and malignant transformation of oral submucous fibrosis. | Gene | 2026 | 41352694 | PubTator, text mining | PubMed |
| Profiling the TRPV4 ankyrin repeat domain interactome and its disruption by neuromuscular disease-causing mutations. | J Biol Chem | 2026 | 41338459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/59341/papers?page=9